about
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reu...
Read More
3.36
0.12
(3.70%)
25,164
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
NLS Pharmaceutics Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..